PMID- 25151210 OWN - NLM STAT- MEDLINE DCOM- 20150825 LR - 20151119 IS - 1532-8414 (Electronic) IS - 1071-9164 (Linking) VI - 20 IP - 11 DP - 2014 Nov TI - Prognostic impact of combined late gadolinium enhancement on cardiovascular magnetic resonance and peak oxygen consumption in ambulatory patients with nonischemic dilated cardiomyopathy. PG - 825-32 LID - S1071-9164(14)01130-0 [pii] LID - 10.1016/j.cardfail.2014.08.005 [doi] AB - BACKGROUND: Peak oxygen consumption (peak VO(2)) and late gadolinium enhancement (LGE) on cardiovascular magnetic resonance (CMR) are prognostic in heart failure. We investigated whether LGE-CMR and peak VO(2)combined had additive value in risk stratifying patients with nonischemic dilated cardiomyopathy (DCM). METHODS AND RESULTS: Fifty-seven DCM patients underwent CMR and cardiopulmonary exercise testing. Cardiac events were cardiac death, hospitalization for decompensated heart failure, or lethal arrhythmia. Twenty-five (44%) were LGE-positive. The median peak VO(2)was 18.5 mL.kg(-1).min(-1). On multivariate analysis, positive LGE (P = .048) and peak VO(2)(P = .003) were independent cardiac event predictors. Cardiac event risk was significantly higher with positive LGE and peak VO(2)< 18.5 mL .kg(-)(1) .min(-)(1) than with negative LGE and peak VO(2)>/= 18.5 mL . kg(-)(1) . min(-)(1) (hazard ratio 12.5; 95% CI 1.57-100; P = .017). In 3 patient groups (group A: no LGE, peak VO(2)>/= 18.5 mL . kg(-)(1) . min(-)(1), n = 18; group B: positive LGE or peak VO(2)< 18.5 mL . kg(-)(1) . min(-)(1), n = 24; group C: positive LGE and peak VO(2)< 18.5 mL . kg(-)(1) . min(-)(1), n = 15) during follow-up (71 +/- 32 months), group C had higher cardiac event rates than the others. CONCLUSIONS: Combined assessment of LGE-CMR and peak VO(2)provides additive prognostic information in ambulatory DCM. CI - Copyright (c) 2014 Elsevier Inc. All rights reserved. FAU - Yamada, Takashi AU - Yamada T AD - Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan. FAU - Hirashiki, Akihiro AU - Hirashiki A AD - Department of Advanced Medicine in Cardiopulmonary Disease, Nagoya University Graduate School of Medicine, Nagoya, Japan. Electronic address: hirasiki@med.nagoya-u.ac.jp. FAU - Okumura, Takahiro AU - Okumura T AD - Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan. FAU - Adachi, Shiro AU - Adachi S AD - Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan. FAU - Shimazu, Shuzo AU - Shimazu S AD - Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan. FAU - Shimizu, Shinya AU - Shimizu S AD - Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan. FAU - Morimoto, Ryota AU - Morimoto R AD - Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan. FAU - Takeshita, Kyosuke AU - Takeshita K AD - Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan. FAU - Naganawa, Shinji AU - Naganawa S AD - Department of Radiology, Nagoya University Graduate School of Medicine, Nagoya, Japan. FAU - Kondo, Takahisa AU - Kondo T AD - Department of Advanced Medicine in Cardiopulmonary Disease, Nagoya University Graduate School of Medicine, Nagoya, Japan. FAU - Murohara, Toyoaki AU - Murohara T AD - Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan. LA - eng PT - Journal Article DEP - 20140821 PL - United States TA - J Card Fail JT - Journal of cardiac failure JID - 9442138 RN - AU0V1LM3JT (Gadolinium) SB - IM MH - Cardiomyopathy, Dilated/*diagnosis/physiopathology MH - Female MH - Follow-Up Studies MH - *Gadolinium MH - Humans MH - Image Enhancement/*methods MH - Magnetic Resonance Imaging, Cine/*methods MH - Male MH - Middle Aged MH - Myocardium/metabolism/pathology MH - *Outpatients MH - Oxygen Consumption/*physiology MH - Prognosis MH - Retrospective Studies MH - Severity of Illness Index MH - Time Factors OTO - NOTNLM OT - Exercise tolerance OT - magnetic resonance imaging OT - prognosis EDAT- 2014/08/26 06:00 MHDA- 2015/08/26 06:00 CRDT- 2014/08/25 06:00 PHST- 2014/02/22 00:00 [received] PHST- 2014/06/20 00:00 [revised] PHST- 2014/08/14 00:00 [accepted] PHST- 2014/08/25 06:00 [entrez] PHST- 2014/08/26 06:00 [pubmed] PHST- 2015/08/26 06:00 [medline] AID - S1071-9164(14)01130-0 [pii] AID - 10.1016/j.cardfail.2014.08.005 [doi] PST - ppublish SO - J Card Fail. 2014 Nov;20(11):825-32. doi: 10.1016/j.cardfail.2014.08.005. Epub 2014 Aug 21.